Skip to content

Effects of oxycodone versus sufentanil on chronic pain after knee replacement in elderly patients: a randomized controlled study

Effect of oxycodone and sufentanil on chronic pain after knee replacement in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084156
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthropathy of knee joint

Interventions

Group Sufentanil:Sufentanil for postoperative analgesia
Group Oxycodone:Oxycodone for postoperative analgesia

Sponsors

Dezhou Hospital, Shandong University Qilu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1) Age 60-89 years old; 2) Body Mass Index (BMI) 18-30kg/m2; 3) ASA Level I-III; 4) To prepare for the first unilateral total knee arthroplasty; 5) Participate and cooperate voluntarily and be able to accurately understand or perform oral or physical assessments.

Exclusion criteria

Exclusion criteria: 1) Patients with serious heart, brain, lung, kidney and other organ lesions before surgery; 2) Have a history of knee injury and surgery; 3) Cumulative joint damage, such as rheumatism, RA, systemic lupus erythematosus and other diseases; 4) History of other chronic pain diseases; 5) The skin of the pilot has ruptured or infected; 6) History of opioid use before assessment; 7) long-term use of psychotropic drugs, abuse of alcohol or illicit drugs; 8) Patients with severe mental illness or who have difficulty communicating; 9) Patients who are allergic to narcotic drugs and remedial analgesics; 10) Patients who participated in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain 6 months after surgery;

Secondary

MeasureTime frame
Perioperative and 6 month postoperative VAS scores (resting and exercise);Preoperative and postoperative delirium assessment;Cognitive function assessment;Satisfaction evaluation (VAS=3);nausea and vomiting;Urinary Retentron;Perioperative respiratory and circulatory complications;LOS(length of stay);Field activity time;

Countries

China

Contacts

Public ContactJianbo Wu

The First Affiliated Hospital of Shandong First Medical University

jianbowu@126.com+86 185 6008 3793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026